XML 39 R14.htm IDEA: XBRL DOCUMENT
v3.19.2

Fair Value Measurements | 12 Months Ended
--- | ---
May 31, 2019
Fair Value Disclosures [Abstract] |
Fair Value Measurements |
NOTE 6 — FAIR VALUE MEASUREMENTS
The following tables present information about the Company's financial assets measured at fair value on a recurring basis as of May 31, 2019 and 2018, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement. Refer to Note 1 — Summary of Significant Accounting Policies for additional detail regarding the Company's fair value measurement methodology.
| AS OF MAY 31, 2019
(Dollars in millions) | ASSETS AT FAIR VALUE |  | CASH AND EQUIVALENTS |  | SHORT-TERM INVESTMENTS |
Cash | $ | 853 |  | $ | 853 |  | $ | — |
Level 1: |  |  |
U.S. Treasury securities | 347 |  | 200 |  | 147 |
Level 2: |  |  |
Commercial paper and bonds | 34 |  | 1 |  | 33 |
Money market funds | 1,637 |  | 1,637 |  | — |
Time deposits | 1,791 |  | 1,775 |  | 16 |
U.S. Agency securities | 1 |  | — |  | 1 |
Total Level 2 | 3,463 |  | 3,413 |  | 50 |
TOTAL | $ | 4,663 |  | $ | 4,466 |  | $ | 197 |
| AS OF MAY 31, 2018
(Dollars in millions) | ASSETS AT FAIR VALUE |  | CASH AND EQUIVALENTS |  | SHORT-TERM INVESTMENTS |
Cash | $ | 415 |  | $ | 415 |  | $ | — |
Level 1: |  |  |
U.S. Treasury securities | 1,178 |  | 500 |  | 678 |
Level 2: |  |  |
Commercial paper and bonds | 451 |  | 153 |  | 298 |
Money market funds | 2,174 |  | 2,174 |  | — |
Time deposits | 925 |  | 907 |  | 18 |
U.S. Agency securities | 102 |  | 100 |  | 2 |
Total Level 2 | 3,652 |  | 3,334 |  | 318 |
TOTAL | $ | 5,245 |  | $ | 4,249 |  | $ | 996 |
The Company elects to record the gross assets and liabilities of its derivative financial instruments on the Consolidated Balance Sheets. The Company's derivative financial instruments are subject to master netting arrangements that allow for the offset of assets and liabilities in the event of default or early termination of the contract. Any amounts of cash collateral received related to these instruments associated with the Company's credit-related contingent features are recorded in Cash and equivalents and Accrued liabilities, the latter of which would further offset against the Company's derivative asset balance (refer to Note 14 — Risk Management and Derivatives). Any amounts of cash collateral posted related to these instruments associated with the Company's credit-related contingent features are recorded in Prepaid expenses and other current assets, which would further offset against the Company's derivative liability balance (refer to Note 14 — Risk Management and Derivatives). Cash collateral received or posted related to the Company's credit related contingent features is presented in the Cash provided by operations component of the Consolidated Statements of Cash Flows. Any amounts of non-cash collateral received, such as securities, are not recorded on the Consolidated Balance Sheets pursuant to U.S. GAAP. For further information related to credit risk, refer to Note 14 — Risk Management and Derivatives. The following tables present information about the Company's derivative assets and liabilities measured at fair value on a recurring basis as of May 31, 2019 and 2018, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
| AS OF MAY 31, 2019
| DERIVATIVE ASSETS |  | DERIVATIVE LIABILITIES
(Dollars in millions) | ASSETS AT FAIR VALUE |  | OTHER CURRENT ASSETS |  | OTHER LONG-TERM ASSETS |  |  | LIABILITIES AT FAIR VALUE |  | ACCRUED LIABILITIES |  | OTHER LONG-TERM LIABILITIES |
Level 2: |  |  |  |  |  |  |
Foreign exchange forwards and options(1) | $ | 611 |  | $ | 611 |  | $ | — |  |  | $ | 51 |  | $ | 51 |  | $ | — |
Embedded derivatives | 11 |  | 5 |  | 6 |  |  | 3 |  | 1 |  | 2 |
TOTAL | $ | 622 |  | $ | 616 |  | $ | 6 |  |  | $ | 54 |  | $ | 52 |  | $ | 2 |
(1) | If the foreign exchange derivative instruments had been netted on the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $50 million as of May 31, 2019. As of that date, the Company had received $289 million of cash collateral from various counterparties related to foreign exchange derivative instruments. No amount of collateral was posted on the Company's derivative liability balance as of May 31, 2019.
| AS OF MAY 31, 2018
| DERIVATIVE ASSETS |  | DERIVATIVE LIABILITIES
(Dollars in millions) | ASSETS AT FAIR VALUE |  | OTHER CURRENT ASSETS |  | OTHER LONG-TERM ASSETS |  |  | LIABILITIES AT FAIR VALUE |  | ACCRUED LIABILITIES |  | OTHER LONG-TERM LIABILITIES |
Level 2: |  |  |  |  |  |  |
Foreign exchange forwards and options(1) | $ | 389 |  | $ | 237 |  | $ | 152 |  |  | $ | 182 |  | $ | 182 |  | $ | — |
Embedded derivatives | 11 |  | 3 |  | 8 |  |  | 8 |  | 2 |  | 6 |
TOTAL | $ | 400 |  | $ | 240 |  | $ | 160 |  |  | $ | 190 |  | $ | 184 |  | $ | 6 |
(1) | If the foreign exchange derivative instruments had been netted on the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $182 million as of May 31, 2018. As of that date, the Company had received $23 million of cash collateral from various counterparties related to foreign exchange derivative instruments. No amount of collateral was posted on the Company's derivative liability balance as of May 31, 2018.
The Company's investment portfolio consists of investments in U.S. Treasury and Agency securities, time deposits, money market funds, corporate commercial paper and bonds. These securities are valued using market prices in both active markets (Level 1) and less active markets (Level 2). As of May 31, 2019, the Company held $158 million of available-for-sale debt securities with maturity dates within one year and $39 million with maturity dates over one year and less than five years in Short-term investments on the Consolidated Balance Sheets. The gross realized gains and losses on sales of securities were immaterial for the fiscal years ended May 31, 2019 and 2018. Unrealized gains and losses on available-for-sale debt securities included in Accumulated other comprehensive income (loss) were immaterial as of May 31, 2019 and 2018. The Company regularly reviews its available-for-sale debt securities for other-than-temporary impairment. For the years ended May 31, 2019 and 2018, the Company did not consider any of its securities to be other-than-temporarily impaired and, accordingly, did not recognize any impairment losses. Included in Interest expense (income), net was interest income related to the Company's investment portfolio of $82 million, $70 million and $27 million for the years ended May 31, 2019, 2018 and 2017, respectively. The Company's Level 3 assets comprise investments in certain non-marketable preferred stock. These Level 3 investments are an immaterial portion of the Company's portfolio and changes in these investments were immaterial during the years ended May 31, 2019 and 2018. No transfers among the levels within the fair value hierarchy occurred during the years ended May 31, 2019 or 2018. For additional information related to the Company's derivative financial instruments, refer to Note 14 — Risk Management and Derivatives. For fair value information regarding Notes payable and Long-term debt, refer to Note 7 — Short-Term Borrowings and Credit Lines and Note 8 — Long-Term Debt, respectively. The carrying amounts of other current financial assets and other current financial liabilities approximate fair value. As of May 31, 2019 and 2018, assets or liabilities required to be measured at fair value on a non-recurring basis were immaterial.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration